Cargando…

Susceptibility Testing Is Key for the Success of Cefiderocol Treatment: A Retrospective Cohort Study

Cefiderocol is a novel siderophore cephalosporin, which has proven in vitro activity against carbapenem-resistant (CR) Gram-negative pathogens and stability towards all carbapenemases. The aim of this study was to describe the first cases of prescriptions and the efficacy of cefiderocol for compassi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bleibtreu, Alexandre, Dortet, Laurent, Bonnin, Remy A., Wyplosz, Benjamin, Sacleux, Sophie-Caroline, Mihaila, Liliana, Dupont, Hervé, Junot, Helga, Bunel, Vincent, Grall, Nathalie, Razazi, Keyvan, Duran, Clara, Tattevin, Pierre, Dinh, Aurélien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911443/ https://www.ncbi.nlm.nih.gov/pubmed/33573148 http://dx.doi.org/10.3390/microorganisms9020282

Ejemplares similares

Compassionate Use of Cefiderocol to Treat a Case of Prosthetic Joint Infection Due to Extensively Drug-Resistant Enterobacter hormaechei
por: Siméon, Soline, et al.
Publicado: (2020)

Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients
por: Zahr, Noël, et al.
Publicado: (2022)

Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study
por: Dinh, Aurélien, et al.
Publicado: (2022)

Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France
por: Jousset, Agnès B., et al.
Publicado: (2023)

Antibiotic Stewardship in Treatment of Osteoarticular Infections Based on Local Epidemiology and Bacterial Growth Times
por: Vidal, Pauline, et al.
Publicado: (2022)

Cefiderocol
por: Soriano, María Cruz, et al.
Publicado: (2022)

Performance evaluation of the UMIC(®) Cefiderocol to determine MIC in Gram-negative bacteria
por: Dortet, Laurent, et al.
Publicado: (2023)

Dual beta-lactam treatment: Pros and cons
por: Guerra, Diogo, et al.
Publicado: (2022)

Retrospective and prospective evaluation of the Carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae
por: Gauthier, Lauraine, et al.
Publicado: (2017)

Genetics of Acquired Antibiotic Resistance Genes in Proteus spp.
por: Girlich, Delphine, et al.
Publicado: (2020)

Impact de la pandémie COVID-19 sur les consommations hospitalières en antibiotiques, étude monocentrique d’un ESR métropolitain
por: Junot, H., et al.
Publicado: (2020)

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium
por: Oueslati, Saoussen, et al.
Publicado: (2022)

Polyclonal Dissemination of OXA-232 Carbapenemase–Producing Klebsiella pneumoniae, France, 2013–2021
por: Emeraud, Cecile, et al.
Publicado: (2022)

Clinical experience of cefiderocol
por: Fariñas, María Carmen
Publicado: (2022)

Mechanism of action of cefiderocol
por: Soriano, Alex, et al.
Publicado: (2022)

Cefiderocol. Summary and conclusions
por: Mensa, José, et al.
Publicado: (2022)

Antibacterial spectrum of cefiderocol
por: Cordero, Desirée Gijón, et al.
Publicado: (2022)

Draft Genome Sequence of the Serratia rubidaea CIP 103234(T) Reference Strain, a Human-Opportunistic Pathogen
por: Bonnin, Rémy A., et al.
Publicado: (2015)

Undetectable Production of the VIM-1 Carbapenemase in an Atlantibacter hermannii Clinical Isolate
por: Girlich, Delphine, et al.
Publicado: (2021)

Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
por: Bilal, Muhammad, et al.
Publicado: (2021)

The role of cefiderocol in clinical practice
por: Maseda, Emilio, et al.
Publicado: (2022)

In Vitro Activity of Cefiderocol on Multiresistant Bacterial Strains and Genomic Analysis of Two Cefiderocol Resistant Strains
por: Padovani, Michela, et al.
Publicado: (2023)

To Be or Not to Be an OXA-48 Carbapenemase
por: Dabos, Laura, et al.
Publicado: (2022)

Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9
por: Gaillot, Susie, et al.
Publicado: (2023)

Risk of Bronchial Complications After Lung Transplantation With Respiratory Corynebacteria. Results From a Monocenter Retrospective Cohort Study
por: Sandot, Adèle, et al.
Publicado: (2023)

Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales
por: Bonnin, Rémy A., et al.
Publicado: (2021)

Emergence and Polyclonal Dissemination of OXA-244–Producing Escherichia coli, France
por: Emeraud, Cecile, et al.
Publicado: (2021)

2752. Outcomes of Patients with Stenotrophomonas maltophilia infections treated with Cefiderocol in PROVE (Retrospective Cefiderocol Chart Review) Study
por: Marcella, Stephen, et al.
Publicado: (2023)

Whole-Genome Sequence of a European Clone II and OXA-72-Producing Acinetobacter baumannii Strain from Serbia
por: Dortet, Laurent, et al.
Publicado: (2015)

Disc Diffusion and ComASP(®) Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine
por: Bianco, Gabriele, et al.
Publicado: (2023)

Evaluation of CHROMagar™ LIN-R for the Screening of Linezolid Resistant Staphylococci from Positive Blood Cultures and Nasal Swab Screening Samples
por: Girlich, Delphine, et al.
Publicado: (2022)

Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria
por: Dortet, Laurent, et al.
Publicado: (2018)

Biochemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum β-Lactamase Activity
por: Oueslati, Saoussen, et al.
Publicado: (2019)

Emergence of New Non–Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Isolates, France
por: Bonnin, Rémy A., et al.
Publicado: (2020)

In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
por: Bonnin, Rémy A., et al.
Publicado: (2023)

Evolution of β-lactamase-mediated cefiderocol resistance
por: Fröhlich, Christopher, et al.
Publicado: (2022)

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
por: Stracquadanio, Stefano, et al.
Publicado: (2022)

Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting
por: Perea, José Ramón Azanza, et al.
Publicado: (2022)

Exploring Cefiderocol Resistance Mechanisms in Burkholderia pseudomallei
por: Hall, Carina M., et al.
Publicado: (2023)

Imported Tickborne Relapsing Fever, France
por: Wyplosz, Benjamin, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_fcb9g1r0a0fr6dc5j88psgtt2n